Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fuji
US Army
Baxter
Farmers Insurance
Healthtrust
McKesson
Fish and Richardson
Accenture
Cerilliant

Generated: October 23, 2017

DrugPatentWatch Database Preview

Desmopressin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desmopressin acetate and what is the scope of desmopressin acetate patent protection?

Desmopressin acetate
is the generic ingredient in ten branded drugs marketed by Apotex Inc, Sun Pharm Inds, Hospira, Ferring Pharms Inc, Impax Labs Inc, Bausch And Lomb, Glenmark Pharms Ltd, Ferring, Zydus Pharms Usa Inc, Sagent Pharms, Mylan Pharms Inc, Serenity Pharms Llc, Actavis Labs Fl Inc, Sun Pharma Global, Bedford, Sun Pharm Inds Ltd, Heritage Pharma, and Teva Pharms Usa, and is included in twenty-six NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Desmopressin acetate has eighty-two patent family members in thirty countries.

There are twenty drug master file entries for desmopressin acetate. Twenty-five suppliers are listed for this compound.

Summary for Generic Name: desmopressin acetate

US Patents:4
Tradenames:10
Applicants:18
NDAs:26
Drug Master File Entries: see list20
Suppliers / Packagers: see list25
Bulk Api Vendors: see list54
Clinical Trials: see list998
Patent Applications: see list5,644
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:desmopressin acetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL076470-002Jul 1, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
STIMATE (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL020355-002Oct 24, 2007RXYesYes► Subscribe► Subscribe► Subscribe
Serenity Pharms Llc
NOCTIVA
desmopressin acetate
SPRAY, METERED;NASAL201656-001Mar 3, 2017RXYesNo► Subscribe► Subscribe ► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SPRAY, METERED;NASAL017922-002Feb 6, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Apotex Inc
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL077414-001Mar 7, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL078271-001Dec 23, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Serenity Pharms Llc
NOCTIVA
desmopressin acetate
SPRAY, METERED;NASAL201656-002Mar 3, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Sun Pharm Inds Ltd
DESMOPRESSIN ACETATE
desmopressin acetate
INJECTABLE;INJECTION091280-001Jan 25, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
STIMATE
desmopressin acetate
SPRAY, METERED;NASAL020355-001Mar 7, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL021795-001May 8, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SOLUTION;NASAL017922-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL017922-003Aug 7, 1996► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-001Mar 30, 1984► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-001Mar 30, 1984► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SPRAY, METERED;NASAL017922-002Feb 6, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: desmopressin acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,560,429Orodispersible dosage forms of desmopressin acetate► Subscribe
9,220,747Methods using desmopressin acetate in orodispersible form► Subscribe
8,143,225Pharmaceutical compositions including low dosages of desmopressin► Subscribe
9,504,647Pharmaceutical formulations of desmopressin► Subscribe
7,947,654Pharmaceutical formulations► Subscribe
8,802,624Methods of treatment using orodispersible desmopressin pharmaceutical formulations► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: desmopressin acetate

Country Document Number Estimated Expiration
Norway335167► Subscribe
BrazilPI0923557► Subscribe
United Kingdom0210397► Subscribe
China102647993► Subscribe
Austria333886► Subscribe
World Intellectual Property Organization (WIPO)2010147981► Subscribe
Japan2012513403► Subscribe
European Patent Office2442821► Subscribe
New Zealand535861► Subscribe
Japan2017160263► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Deloitte
Mallinckrodt
McKesson
Cerilliant
Dow
Chubb
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot